The number of pharmaceutical cargo thefts has fallen in recent years, but manufacturers still need to be vigilant according to an expert who says the holidays are a risky period.
Teva has teamed with Heptares to develop and commercialise easily-deliverable small-molecule calcitonin gene-related peptide (GPCR) antagonists to treat migraine.
New acquisition Sigma Aldrich will play a part in African growth plans in addition to giving it a presence in the preclinical services sector says Merck*.
Novo Nordisk plans to switch all its production plants worldwide to renewable energy, including wind, by 2020.
Manipulated employee records and English-only training materials were among violations cited by the US FDA at two Indian plants, but Sandoz is confident these will be resolved.
Restarting production at the former Ben Venue facility in Ohio will be a “significant task” says Xellia Pharmaceuticals which plans to invest after buying the site from Hikma.